Zipyran, Tableta
Zipyran, Tableta
Authorised
- Praziquantel
- Pyrantel embonate
- Febantel
Product identification
Medicine name:
Zipyran, Tableta
Active substance:
- Praziquantel
- Pyrantel embonate
- Febantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel50.00/milligram(s)1.00Tablet
-
Pyrantel embonate50.00/milligram(s)1.00Tablet
-
Febantel150.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC55
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Calier S.A.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
- 96/061/99-C
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 8/03/2024
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 8/03/2024
Labelling
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 8/03/2024
How useful was this page?:
